Saturday, Apr.27, 2024
miRNA:

hsa-miR-210

Disease:

diffuse large B-cell lymphoma (DLBCL)

Relationship type:

Unspecified

Detection method for miRNA expression:

microarray

Expression pattern of miRNA:

up-regulated

Validated targets of miRNA from the reference:

unknown

Validated targets of miRNA from TarBase:

unknown : More...

Predicted targets: MIRANDA, TARGETSCAN, PICTAR-VERT

 

Description:

Four hsa-miR-As (miR-210, hsa-miR-155, hsa-miR-106a, hsa-miR-17-5p) were expressed at a significantly higher level in DLBCL than in normal tissue. In contrast, the remaining 11 miRNAs (hsa-miR-150, hsa-miR-145, hsa-miR-328, hsa-miR-139, hsa-miR-99a, hsa-miR-10a, hsa-miR-95, hsa-miR-149, hsa-miR-320, hsa-miR-151,let-7e) were expressed at a significantly lower level in DLBCL.A classification tree was computed using four miRNAs (miR-330, miR-17-5p, miR-106a and miR-210) to correctly identify 98% of all 111 cases that were analysed in this study.

 

 

Reference:

MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. | PMID:18537969
Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, Matolcsy A, Bernd HW, Reiniger L, Merz H, Feller AC.
Br J Haematol. 2008 Jun 3. [Epub ahead of print]

 

 
 
 
  miRBase
  Tarbase
  miRGen
  miRGator
  CCBB
  MicroRNA.org
  miRRim
  miRNAMap 2.0
 
 
Please don't hesitate to address comments/questions/suggestions regarding this webpage to: ydwang@hit.edu.cn or yunliu@iu.edu